Carisoprodol Tablet
Product Images NDC 42543-700

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 42543-700). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vensun Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

This Is A Picture Of The Label Carisoprodol Tablets, Usp, 350 mg, 1000s Count. (Carisoprodol Tabs 350mg 1000ct)

Label for Carisoprodol Tablets, USP 350 mg, a prescription oral tablet. The label indicates it is a Schedule IV controlled substance with a strength of 350 mg per tablet. The product is manufactured by ScieGen Pharmaceuticals, Inc. for Vensun Pharmaceuticals, Inc. The label includes storage instructions and a barcode for the package containing 1000 tablets.*

FDA Label Image

This Is A Picture Of The Label Carisoprodol Tablets, Usp, Usp, 350 mg, 100s Count. (Carisoprodol Tabs 350mg 100ct)

Label for Carisoprodol Tablets, USP 350 mg oral tablets in a package of 100. The label shows the product name, dosage strength, and controlled substance Schedule IV symbol. It includes dispensing instructions, storage conditions, manufacturer ScieGen Pharmaceuticals, and labeler Vensun Pharmaceuticals, Inc. There is also a barcode and the product NDC 42543-700-01.*

FDA Label Image

This Is A Picture Of The Label Carisoprodol Tablets, Usp, 350 mg, 500s Count. (Carisoprodol Tabs 350mg 500ct)

Label for Carisoprodol Tablets, USP 350 mg by Vensun Pharmaceuticals, Inc. The label indicates the prescription drug is available in a package of 500 tablets. It includes dosage instructions to take 1 tablet three times daily and at bedtime, storage conditions, and manufacturer information for Vensun Pharmaceuticals and ScieGen Pharmaceuticals. The label features the controlled substance schedule IV (C IV) marking and a barcode.*

FDA Label Image

This In An Image Of The Structural Formula Of Carisoprodol. (Structure)

Chemical structure of carisoprodol shown as a 2D molecular diagram with labeled functional groups and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.